FDA Inspection 1220476 - Fresenius Kabi Oncology Limited - October 10, 2023

Record Details

This FDA Inspection record concerns Fresenius Kabi Oncology Limited, with an inspection on October 10, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Fresenius Kabi Oncology Limited
Inspection Date: October 10, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · dc8162a0-065c-401c-8acb-840e7383f7b6

Violation Codes10

21 CFR 211.113(b)21 CFR 211.160(a)21 CFR 211.160(b)21 CFR 211.18821 CFR 211.19221 CFR 211.194(a)21 CFR 211.22(d)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(10)(v)21 CFR 211.67(b)

Full citation text and observation details available on the Dashboard.